Meetings

2.2a The Committee noted the correspondence.

5.4a The Committee noted the correspondence from the Minister for Health and Social Services.

5.1 The Committee considered and agreed the draft letter, subject to minor changes, for its follow-up inquiry on the contribution of community pharmacy to health services.

Mark Drakeford AM, Minister for Health and Social Services

Professor Roger Walker, Chief Pharmaceutical Officer for Wales

2.1 The Minister responded to questions from Members.

2.2 The Minister agreed to confirm in writing the date by which the joint review by the Chief Medical Officer and Public Health Wales of the national smoking cessation service review will be completed.

7.1 The Committee considered and agreed its approach to its follow-up work on the contribution of community pharmacy to health services in Wales.

NDM5033 Mark Drakeford (Cardiff West)

To propose that the National Assembly for Wales:

Notes the report of the Health and Social Care Committee on its Inquiry into the contribution of community pharmacy to health services in Wales, which was laid in the Table Office on 17 May 2012.

Note: The response of the Minister for Health and Social Services to the report was laid in the Table Office on 4 July 2012.

Supporting Documents:

Report of the Health and Social Care Committee

Response of the Minister for Health and Social Services

The item started at 15.47

NDM5033 Mark Drakeford (Cardiff West)

To propose that the National Assembly for Wales:

Notes the report of the Health and Social Care Committee on its Inquiry into the contribution of community pharmacy to health services in Wales, which was laid in the Table Office on 17 May 2012.

Note: The response of the Minister for Health and Social Services to the report was laid in the Table Office on 4 July 2012.

The motion was agreed in accordance with Standing Order 12.36.

6.1 The Committee considered the draft report on the contribution of community pharmacy to health services in Wales.

HSC(4)-02-12 paper 7

2.1 The Committee considered the key issues on its inquiry into the contribution of community pharmacy to health services in Wales.

7.1 The Committee considered the key issues on its inquiry into the contribution of community pharmacy to health services in Wales and agreed to return to consider its key conclusions and recommendations at its next meeting on 8 February.

HSC(4)-01-12 paper 3

Lesley Griffiths AM, Minister for Health and Social Services

Dr Gwyn Thomas, Chief Information Officer
Andrew Evans, Senior Policy Advisor
Roger Walker, Chief Pharmaceutical Adviser

4.1 The Minister for Health and Social Services and officials responded to questions on the contribution of community pharmacy to health services in Wales.

4.2 The Minister agreed to provide the Committee with a copy of a paper published in the Journal of Public Health on the evaluation of a community pharmacy minor ailment scheme held in North East England.

Letter from the Chair to the Royal Pharmaceutical Society and Community Pharmacy Wales

          HSC(4)-01-12 paper 6

Royal Pharmaceutical Society

          HSC(4)-01-12 paper 7

Community Pharmacy Wales

          HSC(4)-01-12 paper 8

Family Planning Association – follow up to oral evidence session on 16 November

          HSC(4)-01-12 paper 9

HSC(4)-12-11 paper 4

4.2 The Committee noted the additional evidence from Community Pharmacy Wales.

HSC(4)-12-11 paper 1- Community Pharmacy Scotland

Elspeth Weir, Head of Policy & Development, Community Pharmacy Scotland

Malcolm Clubb, Senior Policy and Development Pharmacist, Community Pharmacy Scotland

HSC(4)-12-11 paper 2 - Royal Pharmaceutical Society

Alex MacKinnon, Director for Scotland, Royal Pharmaceutical Society

2.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services.

2.2 Witnesses from Community Pharmacy Scotland agreed to provide:

·         a copy of a report by the Scottish Government on its Review of the Community Pharmacy Public Health Service for Smoking Cessation and Emergency Hormonal Contraception;

·         a link to a report by the University of Manchester on the change in patient consultation patterns in primary care which  investigated the uptake of the Minor Ailments Service in Scotland.

6.1 The Committee considered the issues emerging from its inquiry into the contribution of community pharmacy to health services in Wales.

HSC(4)-11-11 paper 2 – Diabetes UK Cymru

Jason Harding, Policy and Public Affairs Manager, Diabetes UK Cymru

HSC(4)-11-11 paper 3 – Family Planning Association

Melanie Gadd, Project Co-ordinator FPA Jiwsi project

3.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

3.2 The Family Planning Association (FPA) agreed to provide:

·         figures on the number of pharmacies across Wales that are participating in the Emergency Hormonal Contraception (EHC) scheme; and

·         further detail on whether there is variability across Wales in the capability of the community pharmacy network to deliver EHC services.

3.3 The Committee requested a note from its secretariat exploring the extent to which arrangements are in place for pharmacists to port their training and qualifications across local health board boundaries and across the Welsh-English border.

HSC(4)-11-11 paper 1

·         Lisa Turnbull, Policy and Public Affairs Adviser

·         Sue Thomas, Primary Care and Independent Sector Adviser

Break 10.20 – 10.30

2.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

2.2 The witnesses agreed to provide additional information on models used in England to provide primary health care.

HSC(4)-10-11 paper 2

Catherine O’Sullivan, Chief Officer

3.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

3.2 The witnesses agreed to provide information on their review of pharmacy services.

HSC(4)-09-11 paper 5 – Hywel Dda Health Board

HSC(4)-09-11 paper 6 – Betsi Cadwaladr University Health Board

HSC(4)-09-11 paper 7 – Cwm Tâf Health Board

          Chris Martin, Chair, Hywel Dda Health Board

Berwyn Owen, Betsi Cadwaladr University Health Board and Director of the National Medicines Management Programme

Bernadine Rees, Executive Director of Primary, Community and Mental Health, Cwm Tâf Health Board

4.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

HSC(4)-09-11 paper 1- BMA Cymru Wales

          Dr David Bailey, Chair, General Practice Committee Wales

Dr Philip White, General Practice Committee Wales Negotiator

HSC(4)-09-11 paper 2 – The Dispensing Doctors’ Association

          Dr David Baker, Chief Executive

HSC(4)-09-11 paper 3 – Royal College of General Practitioners

          Dr Paul Myers, Chair Elect

Break 10.25 – 10.30

2.1 The witnesses responded to questions from members of the Committee on the contribution of community pharmacy to health services in Wales.

2.2 The Committee requested a map detailing information on the locations of dispensing practices in rural areas.

2.3 Dr Myers agreed to share with the Committee a paper on the pilot study carried out by Aneurin Bevan Health Board on the use of Medicines Use Reviews by community pharmacists.

HSC(4)-07-11 paper 1

          Anne Hinchliffe, Consultant in Pharmaceutical Public Health

          Nuala Brennan, Consultant in Pharmaceutical Public Health

3.1 The witnesses responded to questions from Members of the Committee on the contribution of community pharmacy to health services in Wales.

3.2 The witnesses agreed to provide additional information on: the data available on the take up of medicines use reviews; and existing research relating to patients’ preferences for GP or pharmacy consultations.

3.3 Ms Brennan agreed to give consideration to a streamlined accreditation system for community pharmacists and what it would include, and would share her thoughts with the Committee.

HSC(4)-04-11 paper 2

Russell Goodway, Chief Executive

Ian Cowan, Chair

Chris James, Vice Chair

3.1 The witnesses responded to questions from Members of the Committee on the contribution of community pharmacy to health services in Wales.

3.2 The witnesses agreed to share with the Committee the results of the survey they are undertaking of community pharmacy contractors in Wales into what enhanced services they are currently providing, what additional services they are providing which have been commissioned by local Health Board and what services they think would be of value to their local community but are not currently commissioned by the local Health Board.

HSC(4)-04-11 paper 1

Mair Davies, Chair, Welsh Pharmacy Board

Paul Gimson, Director for Wales

2.1 The witnesses responded to questions from Members of the Committee on the contribution of community pharmacy to health services in Wales.

2.2 The witnesses agreed to provide further information on the model of community pharmacy in Scotland, including the funding of shared IT services.

2.3 The witnesses agreed to provide further information on the joint statement by the Royal Pharmaceutical Society and the Royal College of General Practitioners on collaboration.